Prestige Consumer Healthcare Inc.

DB:PBV Stock Report

Market Cap: €3.8b

Prestige Consumer Healthcare Past Earnings Performance

Past criteria checks 3/6

Prestige Consumer Healthcare's earnings have been declining at an average annual rate of -0.3%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 4.3% per year. Prestige Consumer Healthcare's return on equity is 11.9%, and it has net margins of 18.5%.

Key information

-0.3%

Earnings growth rate

-0.1%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate4.3%
Return on equity11.9%
Net Margin18.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Prestige Consumer Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:PBV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,1112062650
30 Jun 241,1132052640
31 Mar 241,1252092590
31 Dec 231,134-812540
30 Sep 231,127-822460
30 Jun 231,130-842500
31 Mar 231,128-822520
31 Dec 221,1092102520
30 Sep 221,1082092620
30 Jun 221,0952032640
31 Mar 221,0872052600
31 Dec 211,0581892610
30 Sep 211,0221792550
30 Jun 219831792400
31 Mar 219431652240
31 Dec 209571662300
30 Sep 209601632250
30 Jun 209601522270
31 Mar 209631422360
31 Dec 19953-342240
30 Sep 19953-342240
30 Jun 19954-362240
31 Mar 19976-362330
31 Dec 18991642310
30 Sep 181,0203402330
30 Jun 181,0393402330
31 Mar 181,0413402290
31 Dec 171,0263902270
30 Sep 179721072230
30 Jun 179291092100
31 Mar 17882691990
31 Dec 16849721900
30 Sep 16833691860
30 Jun 16824681830
31 Mar 168061001790
31 Dec 157881101660
30 Sep 157861031670
30 Jun 15761881800
31 Mar 15715781670
31 Dec 14668701670
30 Sep 14615521540
30 Jun 14601691340
31 Mar 14597731320

Quality Earnings: PBV has high quality earnings.

Growing Profit Margin: PBV became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PBV has become profitable over the past 5 years, growing earnings by -0.3% per year.

Accelerating Growth: PBV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PBV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (25.4%).

Return on Equity

High ROE: PBV's Return on Equity (11.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 12:14
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Prestige Consumer Healthcare Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olivia Tong CheangBofA Global Research
Linda Bolton-WeiserB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity